SlideShare a Scribd company logo
1 of 13
Clinical Trial Results Transparency:  Challenging the Traditional Paradigm of Medical Communications Christopher Viereck, PhD March 29, 2010
Clinical Trial Results Transparency:  Challenging the Traditional Paradigm of Medical Communications ,[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trial Transparency:  Broad Definition ,[object Object],[object Object],[object Object]
How We Got Here  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Evolution of “Transparency” ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Post-FDAA Success = Finding what is good about the problem  and turning it into an opportunity.
Dissemination of Clinical Trial Results: Traditional Paradigm CT.gov LPLV Press  Release Abstract 1 o Publication Clinical Trial Lifecycle Training 2 o Publications FPFV Med  Info Stds.
Dissemination of Clinical Trial Results:  Impact of FDAAA ,[object Object],[object Object],[object Object],CT.gov LPLV Press  Release Abstract 1 o Publication Clinical Trial Lifecycle Training 2 o Publications CT.gov Results FPFV Med Info Stds.
Dissemination of Clinical Trial Results:    Early Examples of Impact ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Implications of Section 801, FDAAA on Dissemination of Scientific Information:  Less Control ,[object Object],[object Object],[object Object],[object Object]
Barriers to End-User Empowerment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
A Model for Effectively Leveraging CTR: “Gout Resource Center”  for GPs. ,[object Object],[object Object],[object Object],[object Object]
A Model for Effectively Leveraging CTR   “Gout Resource Center” – cont’d ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trial Results Transparency:  Challenging the Traditional Paradigm of Medical Communications ,[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Patient handling equipment market
Patient handling equipment marketPatient handling equipment market
Patient handling equipment marketAkshay Shinde
 
Global cancer vaccine market & pipeline analysis
Global cancer vaccine market & pipeline analysisGlobal cancer vaccine market & pipeline analysis
Global cancer vaccine market & pipeline analysisKuicK Research
 
Global nanomedicine market & pipeline insight 2015
Global nanomedicine market & pipeline insight 2015Global nanomedicine market & pipeline insight 2015
Global nanomedicine market & pipeline insight 2015KuicK Research
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...
MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...
MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...Medicines Discovery Catapult
 
The Stanford-Cancer Genome Atlas Portal Tutorial
The Stanford-Cancer Genome Atlas Portal TutorialThe Stanford-Cancer Genome Atlas Portal Tutorial
The Stanford-Cancer Genome Atlas Portal Tutorialpantcga
 
Therapeutic Targeting of Alzheimer's Disease with a Selective Antibody
Therapeutic Targeting of Alzheimer's Disease with a Selective AntibodyTherapeutic Targeting of Alzheimer's Disease with a Selective Antibody
Therapeutic Targeting of Alzheimer's Disease with a Selective Antibodykphodel
 
Sanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedSanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedCarlynSanguine
 
Career Opportunities in the Life Sciences Industry
Career Opportunities in the Life Sciences IndustryCareer Opportunities in the Life Sciences Industry
Career Opportunities in the Life Sciences IndustryClifford Mintz
 
WON Molecular Tumor Board Presentation
WON Molecular Tumor Board PresentationWON Molecular Tumor Board Presentation
WON Molecular Tumor Board Presentationuwsmph
 
WONIX - Wisconsin Oncology Network of Imagine Excellence
WONIX - Wisconsin Oncology Network of Imagine ExcellenceWONIX - Wisconsin Oncology Network of Imagine Excellence
WONIX - Wisconsin Oncology Network of Imagine Excellenceuwsmph
 
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...Levi Shapiro
 
Myelin repair open science summit 07.31.10 v2
Myelin repair   open science summit 07.31.10 v2Myelin repair   open science summit 07.31.10 v2
Myelin repair open science summit 07.31.10 v2Open Science Summit
 
Effective, Disposable Medical Gowns
Effective, Disposable Medical GownsEffective, Disposable Medical Gowns
Effective, Disposable Medical Gownskphodel
 
Do nice decisions affect decisions in other countries ht ai
Do nice decisions affect decisions in other countries  ht aiDo nice decisions affect decisions in other countries  ht ai
Do nice decisions affect decisions in other countries ht aiOffice of Health Economics
 

What's hot (20)

Patient handling equipment market
Patient handling equipment marketPatient handling equipment market
Patient handling equipment market
 
FDA Issues Guidance For IRBs Feb 2010
FDA Issues Guidance For IRBs  Feb 2010FDA Issues Guidance For IRBs  Feb 2010
FDA Issues Guidance For IRBs Feb 2010
 
Global cancer vaccine market & pipeline analysis
Global cancer vaccine market & pipeline analysisGlobal cancer vaccine market & pipeline analysis
Global cancer vaccine market & pipeline analysis
 
Towse us and eu comparison slides
Towse us and eu comparison slidesTowse us and eu comparison slides
Towse us and eu comparison slides
 
Global nanomedicine market & pipeline insight 2015
Global nanomedicine market & pipeline insight 2015Global nanomedicine market & pipeline insight 2015
Global nanomedicine market & pipeline insight 2015
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...
MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...
MDC Connects Series 2021 | A Guide to Complex Medicines: Where are we now, wh...
 
The Stanford-Cancer Genome Atlas Portal Tutorial
The Stanford-Cancer Genome Atlas Portal TutorialThe Stanford-Cancer Genome Atlas Portal Tutorial
The Stanford-Cancer Genome Atlas Portal Tutorial
 
Ourotech
OurotechOurotech
Ourotech
 
Therapeutic Targeting of Alzheimer's Disease with a Selective Antibody
Therapeutic Targeting of Alzheimer's Disease with a Selective AntibodyTherapeutic Targeting of Alzheimer's Disease with a Selective Antibody
Therapeutic Targeting of Alzheimer's Disease with a Selective Antibody
 
Sanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedSanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updated
 
Career Opportunities in the Life Sciences Industry
Career Opportunities in the Life Sciences IndustryCareer Opportunities in the Life Sciences Industry
Career Opportunities in the Life Sciences Industry
 
WON Molecular Tumor Board Presentation
WON Molecular Tumor Board PresentationWON Molecular Tumor Board Presentation
WON Molecular Tumor Board Presentation
 
Towse future of CER in US
Towse future of CER in USTowse future of CER in US
Towse future of CER in US
 
WONIX - Wisconsin Oncology Network of Imagine Excellence
WONIX - Wisconsin Oncology Network of Imagine ExcellenceWONIX - Wisconsin Oncology Network of Imagine Excellence
WONIX - Wisconsin Oncology Network of Imagine Excellence
 
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
 
Myelin repair open science summit 07.31.10 v2
Myelin repair   open science summit 07.31.10 v2Myelin repair   open science summit 07.31.10 v2
Myelin repair open science summit 07.31.10 v2
 
The Center for Comparative Effectiveness in Genomic Medicine 10.19.09
The Center for Comparative Effectiveness in Genomic Medicine 10.19.09The Center for Comparative Effectiveness in Genomic Medicine 10.19.09
The Center for Comparative Effectiveness in Genomic Medicine 10.19.09
 
Effective, Disposable Medical Gowns
Effective, Disposable Medical GownsEffective, Disposable Medical Gowns
Effective, Disposable Medical Gowns
 
Do nice decisions affect decisions in other countries ht ai
Do nice decisions affect decisions in other countries  ht aiDo nice decisions affect decisions in other countries  ht ai
Do nice decisions affect decisions in other countries ht ai
 
David muchemu's bio
David muchemu's bioDavid muchemu's bio
David muchemu's bio
 

Viewers also liked

Eugm 2012 oneill - perspective on the current environment for adaptive clin...
Eugm 2012   oneill - perspective on the current environment for adaptive clin...Eugm 2012   oneill - perspective on the current environment for adaptive clin...
Eugm 2012 oneill - perspective on the current environment for adaptive clin...Cytel USA
 
Pharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated ReportPharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated Reportshekhar619
 
Future Challenges for Big Pharma
Future Challenges for Big PharmaFuture Challenges for Big Pharma
Future Challenges for Big PharmaTTC, llc
 

Viewers also liked (6)

Eugm 2012 oneill - perspective on the current environment for adaptive clin...
Eugm 2012   oneill - perspective on the current environment for adaptive clin...Eugm 2012   oneill - perspective on the current environment for adaptive clin...
Eugm 2012 oneill - perspective on the current environment for adaptive clin...
 
John Kamp Jan 2010
John Kamp Jan 2010John Kamp Jan 2010
John Kamp Jan 2010
 
Pharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated ReportPharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated Report
 
Future Challenges for Big Pharma
Future Challenges for Big PharmaFuture Challenges for Big Pharma
Future Challenges for Big Pharma
 
Clinical Trial Phases
Clinical Trial PhasesClinical Trial Phases
Clinical Trial Phases
 
Clinical Trials - An Introduction
Clinical Trials - An IntroductionClinical Trials - An Introduction
Clinical Trials - An Introduction
 

Similar to Clinical Trial Transparency: Turning Challenges into Opportunities

Clinical Solutions White Paper
Clinical Solutions White PaperClinical Solutions White Paper
Clinical Solutions White PaperMichael Passanante
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Pubrica
 
Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Brian Ahier
 
Canasita: Enabling Bioscience Processors
Canasita: Enabling Bioscience ProcessorsCanasita: Enabling Bioscience Processors
Canasita: Enabling Bioscience ProcessorsRohan Hubli
 
Statistics-in-Drug-Development-2015-UC-BS.pptx
Statistics-in-Drug-Development-2015-UC-BS.pptxStatistics-in-Drug-Development-2015-UC-BS.pptx
Statistics-in-Drug-Development-2015-UC-BS.pptxDiptoKumerSarker1
 
Early phase drug development and the fda roadmap final version 2ax
Early phase drug development and the fda roadmap final version 2axEarly phase drug development and the fda roadmap final version 2ax
Early phase drug development and the fda roadmap final version 2axE. Dennis Bashaw
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in OncologyAngelo Tinazzi
 
Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...Consorci de Salut i Social de Catalunya
 
Clinical Research Informatics World 2015
Clinical Research Informatics World 2015Clinical Research Informatics World 2015
Clinical Research Informatics World 2015Jaime Hodges
 
SciTech Development Company Presentation
SciTech Development Company PresentationSciTech Development Company Presentation
SciTech Development Company PresentationSciTech Development
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Eric Dollins
 
Conduct of clinical Trials during covid 19 a CTTI webinar
Conduct of clinical Trials during covid 19 a CTTI webinar Conduct of clinical Trials during covid 19 a CTTI webinar
Conduct of clinical Trials during covid 19 a CTTI webinar Pamela Tenaerts
 
Life Raft Group: A New Model for Cancer Research
Life Raft Group: A New Model for Cancer ResearchLife Raft Group: A New Model for Cancer Research
Life Raft Group: A New Model for Cancer ResearchTRAIN Central Station
 
Gene Express Jaima Presentation September 04, 2008 Chiba
Gene Express Jaima Presentation September 04, 2008 ChibaGene Express Jaima Presentation September 04, 2008 Chiba
Gene Express Jaima Presentation September 04, 2008 ChibaDavid Lester
 

Similar to Clinical Trial Transparency: Turning Challenges into Opportunities (20)

Clinical Solutions White Paper
Clinical Solutions White PaperClinical Solutions White Paper
Clinical Solutions White Paper
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...
 
Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations
 
Canasita: Enabling Bioscience Processors
Canasita: Enabling Bioscience ProcessorsCanasita: Enabling Bioscience Processors
Canasita: Enabling Bioscience Processors
 
Statistics-in-Drug-Development-2015-UC-BS.pptx
Statistics-in-Drug-Development-2015-UC-BS.pptxStatistics-in-Drug-Development-2015-UC-BS.pptx
Statistics-in-Drug-Development-2015-UC-BS.pptx
 
Early phase drug development and the fda roadmap final version 2ax
Early phase drug development and the fda roadmap final version 2axEarly phase drug development and the fda roadmap final version 2ax
Early phase drug development and the fda roadmap final version 2ax
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in Oncology
 
VIATAR CTC SOLUTIONS
VIATAR CTC SOLUTIONSVIATAR CTC SOLUTIONS
VIATAR CTC SOLUTIONS
 
Viatar ctc-solutions-9-16-15
Viatar ctc-solutions-9-16-15Viatar ctc-solutions-9-16-15
Viatar ctc-solutions-9-16-15
 
Towse NDDP implications for drug development
Towse NDDP implications for drug developmentTowse NDDP implications for drug development
Towse NDDP implications for drug development
 
CIBM
CIBMCIBM
CIBM
 
Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...Driving innovation procurement forward International Perspective: What can we...
Driving innovation procurement forward International Perspective: What can we...
 
Clinical Research Informatics World 2015
Clinical Research Informatics World 2015Clinical Research Informatics World 2015
Clinical Research Informatics World 2015
 
From biomarkers to diagnostics –the road to success
From biomarkers to diagnostics –the road to successFrom biomarkers to diagnostics –the road to success
From biomarkers to diagnostics –the road to success
 
SciTech Development Company Presentation
SciTech Development Company PresentationSciTech Development Company Presentation
SciTech Development Company Presentation
 
Homework
HomeworkHomework
Homework
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016
 
Conduct of clinical Trials during covid 19 a CTTI webinar
Conduct of clinical Trials during covid 19 a CTTI webinar Conduct of clinical Trials during covid 19 a CTTI webinar
Conduct of clinical Trials during covid 19 a CTTI webinar
 
Life Raft Group: A New Model for Cancer Research
Life Raft Group: A New Model for Cancer ResearchLife Raft Group: A New Model for Cancer Research
Life Raft Group: A New Model for Cancer Research
 
Gene Express Jaima Presentation September 04, 2008 Chiba
Gene Express Jaima Presentation September 04, 2008 ChibaGene Express Jaima Presentation September 04, 2008 Chiba
Gene Express Jaima Presentation September 04, 2008 Chiba
 

Clinical Trial Transparency: Turning Challenges into Opportunities

  • 1. Clinical Trial Results Transparency: Challenging the Traditional Paradigm of Medical Communications Christopher Viereck, PhD March 29, 2010
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Dissemination of Clinical Trial Results: Traditional Paradigm CT.gov LPLV Press Release Abstract 1 o Publication Clinical Trial Lifecycle Training 2 o Publications FPFV Med Info Stds.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.